Certara, Inc. (CERT) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $5.82. It has a SharesGrow Score of 47/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CERT = $17.33 (+197.8% from the current price, the stock appears undervalued). Analyst consensus target is CERT = $10 (+71.8% upside).
Valuation: CERT trades at a trailing Price-to-Earnings (P/E) of -532.6 (S&P 500 average ~25).
Financials: revenue is $419M, +7.7%/yr average growth. Net income is $2M (loss), growing at -103.6%/yr. Net profit margin is -0.4% (negative). Gross margin is 61.5% (+1 pp trend).
Balance sheet: total debt is $11M against $1.1B equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 2.05 (strong liquidity). Debt-to-assets is 0.7%. Total assets: $1.6B.
Analyst outlook: 8 / 14 analysts rate CERT as buy (57%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 40/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 60/100 (Partial), Future 64/100 (Pass), Income 10/100 (Fail).
